Primary Site >> Stomach Cancer
Gene >> MST1R
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. PMID: 8816464 |
Ref: Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa. PMID: 10493952 |
Ref: [Clinical significance and prognostic value of RON protein expression in gastric carcinoma]. PMID: 19035083 |
Ref: Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks. PMID: 21655918 Ref: Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors. PMID: 22287729 |
Ref: Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PMID: 23516391 |
Ref: Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer. PMID: 26721331 Ref: Glycomic and sialoproteomic data of gastric carcinoma cells overexpressing ST3GAL4. PMID: 27077082 |